A Review of Clinical Radioprotection and Chemoprotection for Oral Mucositis
2018 · Translational Oncology · 95 citations
https://doi.org/10.1016/j.tranon.2018.03.014
S
Scott Caroen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
94
Papers
1.2K
Citations
18
h-index
37
i10-index
Scott Caroen is an academic researcher from Epicentre (South Africa). The author has contributed to research in topics: Lung Cancer Research Studies & Cancer therapeutics and mechanisms & Cancer Research and Treatments. The author has an h-index of 18, co-authored 80 publications.
ORCID: 0000-0002-7809-6917Papers by this author
worksREPLATINUM Phase III Randomized Study: RRx-001 + Platinum Doublet Versus Platinum Doublet in Third-Line Small Cell Lung Cancer
2019 · Future Oncology · 50 citations
https://doi.org/10.2217/fon-2019-0317
Nucleocapsid as a next-generation COVID-19 vaccine candidate
2022 · International Journal of Infectious Diseases · 41 citations
https://doi.org/10.1016/j.ijid.2022.06.046
The Development Of RRx-001, A Novel Nitric-Oxide-Mediated Epigenetically Active Anticancer Agent
2015 · Redox Biology · 17 citations
https://doi.org/10.1016/j.redox.2015.09.035
Partial response to carboplatin in an RRx-001 pretreated patient with EGFR-inhibitor-resistance and T790M-negative NSCLC
2016 · Respiratory Medicine Case Reports · 12 citations
https://doi.org/10.1016/j.rmcr.2016.04.007
Supplementary Material for: Case Report of AdAPT-001-Mediated Sensitization to a Previously Failed Checkpoint Inhibitor in a Metastatic Chordoma Patient
2023 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.22284343
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat